Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 285-364-0 | CAS number: 85085-34-3 Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Abies balsamea, Pinaceae.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity: LD50 >2000 mg/kg bw (according to OECD TG 423, EU TM B.1tris)
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 31 Oct 2017 - 15 Nov 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- 17th December 2001
- Deviations:
- yes
- Remarks:
- No chemical analysis of the dose formulation was performed as part of this study. The absence of dose formulation analysis data was considered not to prejudice the overall GLP status of the study and the scientific reliability of the study conclusions.
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Version / remarks:
- Commission Regulation (EC) No 440/2008 of 30 May 2008, B.1.Tris, EPA Health Effects Test Guidelines (OPPTS 870.1100), United States, EPA 712-C-98-190 (1998)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: Botanical source and Lot# 67919
- Expiration date of the lot/batch: 13 septembre 2018
- Purity test date: UVCB, considered 100% pure
RADIOLABELLING INFORMATION (if applicable)
- Radiochemical purity:
- Specific activity:
- Locations of the label:
- Expiration date of radiochemical substance:
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Room temperature (15-25 °C, ≤ 70 RH%), protected from light, avoid contact with iron. - Species:
- rat
- Strain:
- Wistar
- Remarks:
- Crl:WI Wistar rats
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Germany
- Females (if applicable) nulliparous and non-pregnant: yes
- Age at study initiation: 10 weeks old
- Weight at study initiation: 232-258g
- Fasting period before study: night before treatment
- Housing: 3 animals / cage.
- Diet (e.g. ad libitum): ssniff® SM R/M (ad libitum except for night before treatment)
- Water (e.g. ad libitum): municipal tap water in 500mL bottles (ad libitum)
- Acclimation period: at least 19 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20.5 - 25.5 deg C
- Humidity (%): 32 - 91%
- Air changes (per hr): 15-20 air exchanges/hr
- Photoperiod (hrs dark / hrs light): 12 hours (6am to 6pm)
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 200mg/mL
- Amount of vehicle (if gavage): 10mL/kg bw
- Lot/batch no. (if required): lot A0386839 from Acros Organics (exp 31 july 2019)
MAXIMUM DOSE VOLUME APPLIED: limit dose of 2000mg/kg bw
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: as required by guideline OECD 423 - Doses:
- 2000mg/kg
- No. of animals per sex per dose:
- 3 animals/dose (if no or one animal dies, same dose is repeated 3 animals)
Only females (nulliparous and non-pregnant animals) are part of the study - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: 30min, 1, 2, 3, 4, 6 hrs, then once a day for 14 days
- Necropsy of survivors performed: yes
- Histopathological examination was not performed
- Other examinations performed: skin and fur, eyes and mucous membranes and also respiratory, circulatory, autonomic and central nervous system, somatomotor activity and behaviour pattern. Particular attention will be directed to observation of tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma. Body weights at different periods will be recorded - Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality at a dose level of 2000 mg/kg bw.
- Clinical signs:
- other: At dose level of 2000 mg/kg bw, the following symptoms were observed from Day 0 up to Day 1: hunched back (6 out of 6 animals), slightly decreased activity (3 out of 6 animals) and slight incoordination (1 out of 6 animals). From Day 2 all animals were sy
- Gross pathology:
- Necropsy:
There was no evidence of the macroscopic observations at a dose level of 2000 mg/kg bw. - Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- Under the conditions of this study, the acute oral LD50 value of the test item Fir Needle Oil Canadian (Fir, Abies Balsamea, ext) was found to be above 2000 mg/kg bw in female Crl:WI rats.
According to the GHS criteria, Fir Needle Oil Canadian (Fir, Abies Balsamea, ext) can be ranked as "Category 5" for acute oral exposure. - Executive summary:
The single-doseoral toxicity of Fir Needle Oil Canadian (Fir, Abies Balsamea, ext) was performed according to the acute toxic class method (OECD 423 and Commission Regulation (EC) No 440/2008of30 May2008, B.1.tris) in female Crl:WI Wistar rats.
Two groups of 3 female Crl:WI rats were treated with the test item at a dose level of 2000 mg/kg bw (Group 1 and Group 2).
A single oral treatment was carried out by gavage for each animal after an overnight food withdrawal. Food was made available again 3 hours after the treatment.The test item was formulated in corn oil at a concentration of 200 mg/mL at a dose volume of 10 mL/kg bw. Initially, three females (Group 1) were treated at a dose level of 2000 mg/kg bw. As no mortality was observed, a confirmatory group (Group 2) was treated at the same dose level. No other mortality was observed in the confirmatory group, therefore no further testing was required according to OECD 423 and CommissionRegulation(EC) No440/2008 of 30 May 2008, B.1.tris.
Clinical observations were performed at 30 minutes, 1, 2, 3, 4 and 6 hours after dosing and daily for 14 days thereafter. Body weight was measured on Days -1, 0, 7 and 14 (before necropsy). All animals were subjected to a necropsy and a macroscopic examination.
The results of the study were summarized as follows:
Mortality
Fir Needle Oil Canadian (Fir, Abies Balsamea, ext) did not cause any mortality at a dose level of 2000 mg/kg bw.
Clinical Observations
At dose level of 2000 mg/kg bw, the following symptoms were observed from Day 0 up to Day 1: hunched back (6 out of 6 animals), slightly decreased activity (3 out of 6 animals) and slight incoordination (1 out of 6 animals). From Day 2 all animals were symptom-free.
Body Weight and Body Weight Gain
There were no effects on body weights or body weight gains that could be attributed to treatment with of Fir Needle Oil Canadian (Fir, Abies Balsamea, ext).
Necropsy
There was no evidence of the macroscopic observations at a dose level of 2000 mg/kg bw
Under the conditions of this study, the acute oral LD50value of the test item Fir Needle Oil Canadian (Fir, Abies Balsamea, ext) was found to be above 2000 mg/kg bw in female Crl:WI rats. According to the GHS criteria, Fir Needle Oil Canadian (Fir, Abies Balsamea, ext) can be ranked as "Category 5" for acute oral exposure.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.